Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1245816-09-4 | MDL No. : | MFCD12028644 |
Formula : | C8H9BN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IZIRYCSGUBTOOF-UHFFFAOYSA-N |
M.W : | 175.98 | Pubchem ID : | 44119479 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 50.89 |
TPSA : | 69.14 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.79 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.82 |
Log Po/w (WLOGP) : | -0.45 |
Log Po/w (MLOGP) : | -0.28 |
Log Po/w (SILICOS-IT) : | -0.15 |
Consensus Log Po/w : | -0.01 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.89 |
Solubility : | 2.25 mg/ml ; 0.0128 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.85 |
Solubility : | 2.46 mg/ml ; 0.014 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.19 |
Solubility : | 1.15 mg/ml ; 0.00652 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In 1,4-dioxane; water; at 95.0℃; for 2.0h;Sealed tube; | Example 2881 -(3-[2-amino-6-(4-methyl-1 H-indazol-5-yl)pyrimidin-4-yl]amino}propyl)pyrrolidin-2-one.A mixture of 1 -{3-[(2-amino-6-chloropyrimidin-4-yl)amino]propyl}pyrrolidin-2-one (27 mg, 0.10 mmol), (4-methyl-i H-indazol-5-yl)boronic acid (19 mg, 0.11 mmol), potassium carbonate (28 mg, 0.20 mmol) and palladium tetrakis(triphenylphosphine)palladium (0) (6 mg, 0.005 mmol) in 1,4-dioxane (4 mL) and water (1 mL) was heated in a sealed tube at 95C for 2 h. The reactionmixture was concentrated and purified by preparative HPLC. LCMS [M+H] 366. | |
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In 1,4-dioxane; water; at 95.0℃; for 2.0h;Sealed tube; | Example 288 1- (3-[2-amino-6-(4-methyl-1 H-indazol-5-yl)pyrimidin-4-yl]amino}propyl)pyrrolidi 2- one. A mixture of 1-{3-[(2-amino-6-chloropyrimidin-4-yl)amino]propyl}pyrrolidin-2-one (27 mg, 0.10 mmol), (4-methyl-1 H-indazol-5-yl)boronic acid (19 mg, 0.1 1 mmol), potassium carbonate (28 mg, 0.20 mmol) and palladium tetrakis(triphenylphosphine)palladium (0) (6 mg, 0.005 mmol) in 1 ,4-dioxane (4 ml_) and water (1 ml_) was heated in a sealed tube at 95C for 2 h. The reaction mixture was concentrated and purified by preparative HPLC. LCMS [M+H]+ 366. |
[ 1245816-25-4 ]
3-Methyl-1H-indazol-5-yl-5-boronic acid
Similarity: 0.93
[ 885068-10-0 ]
1H-Indazol-6-yl-6-boronic acid
Similarity: 0.93
[ 1245816-10-7 ]
(5-Methyl-1H-indazol-4-yl)boronic acid
Similarity: 0.88
[ 1310383-42-6 ]
(5-Methyl-1H-indazol-6-yl)boronic acid
Similarity: 0.88
[ 1245816-25-4 ]
3-Methyl-1H-indazol-5-yl-5-boronic acid
Similarity: 0.93
[ 885068-10-0 ]
1H-Indazol-6-yl-6-boronic acid
Similarity: 0.93
[ 1245816-10-7 ]
(5-Methyl-1H-indazol-4-yl)boronic acid
Similarity: 0.88
[ 1310383-42-6 ]
(5-Methyl-1H-indazol-6-yl)boronic acid
Similarity: 0.88